Home/Filings/4/0000950170-25-031269
4//SEC Filing

Kieffer Timothy 4

Accession 0000950170-25-031269

CIK 0001572616other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 9:02 PM ET

Size

8.3 KB

Accession

0000950170-25-031269

Insider Transaction Report

Form 4
Period: 2025-02-27
Kieffer Timothy
Chief Scientific Officer
Transactions
  • Award

    Stock Option (right to buy)

    2025-02-27+35,28035,280 total
    Exercise: $15.00Exp: 2034-01-31Common Stock (35,280 underlying)
  • Award

    Stock Option (right to buy)

    2025-02-27+169,700169,700 total
    Exercise: $1.46Exp: 2035-02-26Common Stock (169,700 underlying)
Footnotes (2)
  • [F1]The stock option vests and becomes exercisable in equal installments on each of the first four anniversaries of the grant date, subject to the Reporting Persons's continuing in employment through each such vesting date.
  • [F2]In connection with the Issuer's initial public offering, on February 1, 2024 the Reporting Person was granted, subject to the satisfaction of certain performance criteria, an option to purchase 58,800 shares of common stock to vest in the form of shares of the Issuer's common stock in four substantially equal installments on December 31, 2024 and each of the first three anniversaries thereof. On February 27, 2025, the Issuer's administrator determined that the performance criteria were partially met, resulting in 35,280 shares subject to such option being earned, of which 25% vested on December 31, 2024 and the remaining 75% will vest in substantially equal installments on the first three anniversaries thereof.

Documents

1 file

Issuer

FRACTYL HEALTH, INC.

CIK 0001572616

Entity typeother

Related Parties

1
  • filerCIK 0002004011

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 9:02 PM ET
Size
8.3 KB